Phase IB study of 25-hydroxyvitamin D(3) treatment to diminish suppressor cells in head and neck cancer patients.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/3B937ABC.svg?ark=w1%2F20260515%2F3B937ABC&value=id)](https://nobleid.org/work/w1/20260515/3B937ABC)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors